Invention Application
US20120142745A1 NOVEL PHENYL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
失效
新型苯基氧杂环丁酮衍生物作为磷酸酯1-磷酸（S1P）受体调节剂
- Patent Title: NOVEL PHENYL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
- Patent Title (中): 新型苯基氧杂环丁酮衍生物作为磷酸酯1-磷酸（S1P）受体调节剂
-
Application No.: US13295324Application Date: 2011-11-14
-
Publication No.: US20120142745A1Publication Date: 2012-06-07
- Inventor: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha Bin Im
- Applicant: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha Bin Im
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61P27/02 ; A61P29/00 ; A61P19/02 ; A61P9/10 ; A61P17/02 ; A61P11/00 ; C07D271/06 ; A61P35/00
Abstract:
The present invention relates to novel phenyl oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US08486918B2 Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor Public/Granted day:2013-07-16
Information query
